Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Apr;61(4):354-61.
doi: 10.1136/thx.2005.041830.

COPD exacerbations . 3: Pathophysiology

Affiliations
Review

COPD exacerbations . 3: Pathophysiology

D E O'Donnell et al. Thorax. 2006 Apr.

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with increased morbidity and mortality. The effective management of COPD exacerbations awaits a better understanding of the underlying pathophysiological mechanisms that shape its clinical expression. The clinical presentation of exacerbations of COPD is highly variable and ranges from episodic symptomatic deterioration that is poorly responsive to usual treatment, to devastating life threatening events. This underscores the heterogeneous physiological mechanisms of this complex disease, as well as the variation in response to the provoking stimulus. The derangements in ventilatory mechanics, muscle function, and gas exchange that characterise severe COPD exacerbations with respiratory failure are now well understood. Critical expiratory flow limitation and the consequent dynamic lung hyperinflation appear to be the proximate deleterious events. Similar basic mechanisms probably explain the clinical manifestations of less severe exacerbations of COPD, but this needs further scientific validation. In this review we summarise what we have learned about the natural history of COPD exacerbations from clinical studies that have incorporated physiological measurements. We discuss the pathophysiology of clinically stable COPD and examine the impact of acutely increased expiratory flow limitation on the compromised respiratory system. Finally, we review the chain of physiological events that leads to acute ventilatory insufficiency in severe exacerbations.

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared.

References

    1. Seemungal T A, Donaldson C G, Paul E A.et al Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 19981571418–1422. - PubMed
    1. O'Donnell D E, Aaron S, Bourbeau J.et al Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2003. Can Respir J 200310(Suppl A)11–65A. - PubMed
    1. Bhowmik A, Seemungal T A R, Sapsford R J.et al Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 200055114–120. - PMC - PubMed
    1. Vincken W, van Noord J A, Greefhorfst A P M.et al Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 200219209–216. - PubMed
    1. Poole P J, Black P N. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 20013221271–1274. - PMC - PubMed

MeSH terms